Search

Your search keyword '"Krishnasamy, Rathika"' showing total 215 results

Search Constraints

Start Over You searched for: Author "Krishnasamy, Rathika" Remove constraint Author: "Krishnasamy, Rathika"
215 results on '"Krishnasamy, Rathika"'

Search Results

1. Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental Start

2. Consumer involvement in the development and dissemination of chronic kidney disease guidelines: a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines

5. Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team

6. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

7. Development of an international glossary for clinical guidelines collaboration

8. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

9. Consumer involvement in the development and dissemination of chronic kidney disease guidelines: a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines

13. Greater hemodialysis exposure (“quotidian hemodialysis”) has different mortality associations by patient age group

17. Australian and New Zealand Living Guideline cholesterol‐lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence‐practice gap.

18. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

23. Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

25. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

29. Supplemental Material, sj-docx-1-ptd-10.1177_08968608231175826 - Association of Incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: The balANZ trial

30. Impact of haemodialysis hours on outcomes in older patients

33. Dialysis modality utilization patterns and mortality in older persons initiating dialysis in Australia and New Zealand

37. Supplemental Material, sj-docx-1-ptd-10.1177_08968608221126849 - Range and consistency of gastrointestinal outcomes reported in peritoneal dialysis trials: A systematic review

41. Impact of haemodialysis hours on outcomes in older patients.

42. International peritoneal dialysis training practices and the risk of peritonitis

46. Effect of a medium cut‐off dialyzer on protein‐bound uremic toxins and mineral metabolism markers in patients on hemodialysis

48. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop

49. International peritoneal dialysis training practices and the risk of peritonitis.

Catalog

Books, media, physical & digital resources